Lersivirine 是非核苷逆转录的抑制剂 (NNRTI; IC50=119 nM),对 NNRTI 耐药病毒具有优异的抑制效果。Lersivirine 对野生型人类免疫缺陷病毒 (HIV) 和临床相关 NNRTI 耐药菌株显示出强大的抗逆转录病毒活性。 Lersivirine is a second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) under development for HIV infection therapy.
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
Lersivirine
Dangerous GoodsCAS number:473921-12-9 molecular formula:C17H18N4O2
overview
compound introduction
Specs
| Chinese alias | 3-氰基-5-[[3,5-二乙基-1-(2-羟基乙基)-1H-吡唑-4-基]氧基]苯腈 | ||
| English alias | Q27287760 | UK 453,061 | Lersivirine [USAN] | UNII-R3ZGC15A9A | 5-{[3,5-Diethyl-1-(2-Hydroxyethyl)-1h-Pyrazol-4-Yl]oxy}benzene-1,3-Dicarbonitrile | SCHEMBL16241879 | UK-453061 | 2won | CJ12420 | D09634 | DB11649 | A872162 | BDBM50483552 | Lersivirine (USA | ||
| CAS number | 473921-12-9 | molecular formula | C17H18N4O2 |
| molecular weight | 310.35 g/mol | Exact mass | ≥98% |
| PSA | 94.900 Ų | logp | 2.1 |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
pictogram:
GHS08
Signal word:
Warning
Hazard Statement:
H373: 通过长时间或反复暴露对器官造成损害 H412: 对水生生物有害并具有长期持续影响 H361: 怀疑破坏生育力或未出生的孩子
Statement of Preventive Measures:
P273: 避免释放到环境中。 P280: 戴防护手套/穿防护服/戴防护眼罩/戴防护面具。 P405: 密闭存放 P501: 将内容物/容器处理到。。。 P260: 不要吸入灰尘/烟雾/气体/雾/蒸汽/喷雾。 P203: 使用前,获取、阅读并遵守所有安全说明。 P318: 如果暴露或担心,请就医。 P319: 如果你感到不适,请寻求医疗帮助。
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 0 shareMSDS





